Gender-associated genomic differences in colorectal cancer: Clinical insight from feminization of male cancer cells

International Journal of Molecular Sciences

Volumn 15, Issue 10, 2014, Pages 17344-17365

  Ali, Rola H ^a   Marafie, Makia J ^b   Bitar, Milad S ^a   Al Dousari, Fahad ^c   Ismael, Samar ^c   Haider, Hussain Bin ^a   Al Ali, Waleed ^a   Al Mulla, Fahd ^a   Jacob, Sindhu P ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

^b MINISTRY OF HEALTH   (Kuwait)

^c Ministry of Interior   (Kuwait)

Author keywords

Colorectal cancer; Comparative genomic hybridization; Copy number aberration; Gender; X chromosome

Indexed keywords

B RAF KINASE;

ADULT; AGED; ALLELOTYPING; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME LOSS; COLORECTAL CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; CPG ISLAND; DISEASE FREE SURVIVAL; FEMALE; FEMINIZATION; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GAIN OF FUNCTION MUTATION; GENE FREQUENCY; GENE LOCUS; GENETIC PROCEDURES; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MISMATCH REPAIR; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; VERY ELDERLY; X CHROMOSOME; Y CHROMOSOME; COLORECTAL TUMOR; DEMOGRAPHY; GENETICS; HUMAN GENOME; MORTALITY; PATHOLOGY; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, X; CHROMOSOMES, HUMAN, Y; COLORECTAL NEOPLASMS; COMPARATIVE GENOMIC HYBRIDIZATION; DEMOGRAPHY; DISEASE-FREE SURVIVAL; DNA COPY NUMBER VARIATIONS; FEMALE; FEMINIZATION; GENOME, HUMAN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; PROTO-ONCOGENE PROTEINS B-RAF; SEX FACTORS;

EID: 84907829572     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms151017344     Document Type: Article

References (59)

1. Markowitz, S. D.; Bertagnolli, M. M. Molecular origins of cancer: Molecular basis of colorectal cancer. N. Engl. J. Med. 2009, 361, 2449-2460.
2. Ried, T.; Knutzen, R.; Steinbeck, R.; Blegen, H.; Schröck, E.; Heselmeyer, K.; du Manoir, S.; Auer, G. Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 1996, 15, 234-245.
3. Bomme, L.; Bardi, G.; Pandis, N.; Fenger, C.; Kronborg, O.; Heim, S. Clonal karyotypic abnormalities in colorectal adenomas: Clues to the early genetic events in the adenoma-carcinoma sequence. Genes Chromosomes Cancer 1994, 10, 190-196.
4. Bardi, G.; Sukhikh, T.; Pandis, N.; Fenger, C.; Kronborg, O.; Heim, S. Karyotypic characterization of colorectal adenocarcinomas. Genes Chromosomes Cancer 1995, 12, 97-109.
5. Al-Mulla, F.; Keith, W. N.; Pickford, I. R.; Going, J. J.; Birnie, G. D. Comparative genomic hybridization analysis of primary colorectal carcinomas and their synchronous metastases. Genes Chromosomes Cancer 1999, 24, 306-314.
6. De Angelis, P. M.; Clausen, O. P.; Schjolberg, A.; Stokke, T. Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes. Br. J. Cancer 1999, 80, 526-535.
7. He, Q. J.; Zeng, W. F.; Sham, J. S.; Xie, D.; Yang, X. W.; Lin, H. L.; Zhan, W. H.; Lin, F.; Zeng, S. D.; Nie, D.; et al. Recurrent genetic alterations in 26 colorectal carcinomas and 21 adenomas from Chinese patients. Cancer Genet. Cytogenet. 2003, 144, 112-118.
8. Al-Mulla, F.; Behbehani, A. I.; Bitar, M. S.; Varadharaj, G.; Going, J. J. Genetic profiling of stage I and II colorectal cancer may predict metastatic relapse. Mod. Pathol. 2006, 19, 648-658.
9. Tsafrir, D.; Bacolod, M.; Selvanayagam, Z.; Tsafrir, I.; Shia, J.; Zeng, Z.; Liu, H.; Krier, C.; Stengel, R. F.; Barany, F.; et al. Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res. 2006, 66, 2129-2137.
10. Dorak, M. T.; Karpuzoglu, E. Gender differences in cancer susceptibility: An inadequately addressed issue. Front. Genet. 2012, 3, 268.
11. Dutrillaux, B.; Muleris, M.; Seureau, M. G. Imbalance of sex chromosomes, with gain of early-replicating X, in human solid tumors. Int. J. Cancer 1986, 38, 475-479.
12. Muleris, M.; Dutrillaux, A. M.; Salmon, R. J.; Dutrillaux, B. Sex chromosomes in a series of 79 colorectal cancers: Replication pattern, numerical, and structural changes. Genes Chromosomes Cancer 1990, 1, 221-227.
13. Unotoro, J.; Kamiyama, H.; Ishido, Y.; Yaginuma, Y.; Kasamaki, S.; Sakamoto, K.; Oota, A.; Ishibashi, Y.; Kamano, T. Analysis of the relationship between sex and chromosomal aberrations in colorectal cancer by comparative genomic hybridization. J. Int. Med. Res. 2006, 34, 397-405.
14. Brim, H.; Lee, E.; Abu-Asab, M. S.; Chaouchi, M.; Razjouyan, H.; Namin, H.; Goel, A.; Schäffer A. A.; Ashktorab, H. Genomic aberrations in an African American colorectal cancer cohort reveals a MSI-specific profile and chromosome X amplification in male patients. PLoS One 2012, 7, e40392.
15. Diskin, S. J.; Eck, T.; Greshock, J.; Mosse, Y. P.; Naylor, T.; Stoeckert, C. J., Jr.; Weber, B. L.; Maris, J. M.; Grant, G. R. STAC: A method for testing the significance of DNA copy number aberrations across multiple array-CGH experiments. Genome Res. 2006, 16, 1149-1158.
16. Beroukhim, R.; Getz, G.; Nghiemphu, L.; Barretina, J.; Hsueh, T.; Linhart, D.; Vivanco, I.; Lee, J. C.; Huang, J. H.; Alexander, S.; et al. Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma. Proc. Natl. Acad. Sci. USA 2007, 104, 20007-20012.
17. Rim, S. H.; Seeff, L.; Ahmed, F.; King, J. B.; Coughlin, S. S. Colorectal cancer incidence in the United States, 1999-2004: An updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program. Cancer 2009, 115, 1967-1976.
18. Purim, O.; Gordon, N.; Brenner, B. Cancer of the colon and rectum: Potential effects of sex-age interactions on incidence and outcome. Med. Sci. Monit. 2013, 19, 203-209.
19. DeCosse, J. J.; Ngoi, S. S.; Jacobson, J. S.; Cennerazzo, W. J. Gender and colorectal cancer. Eur. J. Cancer Prev. 1993, 2, 105-115.
20. McCashland, T. M.; Brand, R.; Lyden, E.; de Garmo, P.; Project, C. R. Gender differences in colorectal polyps and tumors. Am. J. Gastroenterol. 2001, 96, 882-886.
21. Takada, H.; Ohsawa, T.; Iwamoto, S.; Yoshida, R.; Nakano, M.; Imada, S.; Yoshioka, K.; Okuno, M.; Masuya, Y.; Hasegawa, K.; et al. Changing site distribution of colorectal cancer in Japan. Dis. Colon Rectum 2002, 45, 1249-1254.
22. Ward, R.; Meagher, A.; Tomlinson, I.; O'Connor, T.; Norrie, M.; Wu, R.; Hawkins, N. Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut 2001, 48, 821-829.
23. Hawkins, N.; Norrie, M.; Cheong, K.; Mokany, E.; Ku, S. L.; Meagher, A.; O'Connor, T.; Ward, R. CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology 2002, 122, 1376-1387.
24. Ogino, S.; Cantor, M.; Kawasaki, T.; Brahmandam, M.; Kirkner, G. J.; Weisenberger, D. J.; Campan, M.; Laird, P. W.; Loda, M.; Fuchs, C. S. CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies. Gut 2006, 55, 1000-1006.
25. Ogino, S.; Goel, A. Molecular classification and correlates in colorectal cancer. J. Mol. Diagn. 2008, 10, 13-27.
26. Ogino, S.; Kawasaki, T.; Kirkner, G. J.; Loda, M.; Fuchs, C. S. CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: Possible associations with male sex and KRAS mutations. J. Mol. Diagn. 2006, 8, 582-588.
27. Elsaleh, H.; Joseph, D.; Grieu, F.; Zeps, N.; Spry, N.; Iacopetta, B. Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet 2000, 355, 1745-1750.
28. Kotake, K.; Honjo, S.; Sugihara, K.; Kato, T.; Kodaira, S.; Takahashi, T.; Yasutomi, M.; Muto, T.; Koyama, Y. Changes in colorectal cancer during a 20-year period: An extended report from the multi-institutional registry of large bowel cancer, Japan. Dis. Colon Rectum 2003, 46, S32-43.
29. Micheli, A.; Ciampichini, R.; Oberaigner, W.; Ciccolallo, L.; de Vries, E.; Izarzugaza, I.; Zambon, P.; Gatta, G.; de Angelis, R. EUROCARE Working Group. The advantage of women in cancer survival: An analysis of EUROCARE-4 data. Eur. J. Cancer 2009, 45, 1017-1027.
30. Hendifar, A.; Yang, D.; Lenz, F.; Lurje, G.; Pohl, A.; Lenz, C.; Ning, Y.; Zhang, W.; Lenz, H. J. Gender disparities in metastatic colorectal cancer survival. Clin. Cancer Res. 2009, 15, 6391-6397.
31. Majek, O.; Gondos, A.; Jansen, L.; Emrich, K.; Holleczek, B.; Katalinic, A.; Nennecke, A.; Eberle, A.; Brenner, H. GEKID Cancer Survival Working Group. Sex differences in colorectal cancer survival: Population-based analysis of 164, 996 colorectal cancer patients in Germany. PLoS One 2013, 8, e68077.
32. Koo, J. H.; Jalaludin, B.; Wong, S. K.; Kneebone, A.; Connor, S. J.; Leong, R. W. Improved survival in young women with colorectal cancer. Am. J. Gastroenterol. 2008, 103, 1488-1495.
33. Koo, J. H.; Leong, R. W. Sex differences in epidemiological, clinical and pathological characteristics of colorectal cancer. J. Gastroenterol. Hepatol. 2010, 25, 33-42.
34. Ponz de Leon, M.; Sant, M.; Micheli, A.; Sacchetti, C.; di Gregorio, C.; Fante, R.; Zanghieri, G.; Melotti, G.; Gatta, G. Clinical and pathologic prognostic indicators in colorectal cancer. A population-based study. Cancer 1992, 69, 626-635.
35. Manfredi, S.; Bouvier, A. M.; Lepage, C.; Hatem, C.; Dancourt, V.; Faivre, J. Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. Br. J. Surg. 2006, 93, 1115-1122.
36. Slattery, M. L.; Potter, J. D.; Curtin, K.; Edwards, S.; Ma, K. N.; Anderson, K.; Schaffer, D.; Samowitz, W. S. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Cancer Res. 2001, 61, 126-130.
37. Shahabi, S.; He, S.; Kopf, M.; Mariani, M.; Petrini, J.; Scambia, G.; Ferlini, C. Free testosterone drives cancer aggressiveness: Evidence from US population studies. PLoS One 2013, 8, e61955.
38. Orsted, D. D.; Nordestgaard, B. G.; Bojesen, S. E. Plasma testosterone in the general population, cancer prognosis and cancer risk: A prospective cohort study. Ann. Oncol. 2014, 25, 712-718.
39. Al-Qallaf, D. A.; Al-Mulla, F. Colorectal Carcinoma in Kuwait: Apoptosis and Its Relation to Clinicopathological Characteristics, p53 Expression and ki-ras Proto-Oncogene Mutations. Ph. D. Thesis, Kuwait University, Kuwait City, Kuwait, 2012.
40. Terracciano, L. M.; Bernasconi, B.; Ruck, P.; Stallmach, T.; Briner, J.; Sauter, G.; Moch, H.; Vecchione, R.; Pollice, L.; Pettinato, G.; et al. Comparative genomic hybridization analysis of hepatoblastoma reveals high frequency of X-chromosome gains and similarities between epithelial and stromal components. Hum. Pathol. 2003, 34, 864-871.
41. Visakorpi, T.; Hyytinen, E.; Kallioniemi, A.; Isola, J.; Kallioniemi, O. P. Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization. Am. J. Pathol. 1994, 145, 624-630.
42. Looijenga, L. H.; Oosterhuis, J. W. Pathogenesis of testicular germ cell tumours. Rev. Reprod. 1999, 4, 90-100.
43. Spatz, A.; Borg, C.; Feunteun, J. X-chromosome genetics and human cancer. Nat. Rev. Cancer 2004, 4, 617-629.
44. Muscatelli, F.; Walker, A. P.; de Plaen, E.; Stafford, A. N.; Monaco, A. P. Isolation and characterization of a MAGE gene family in the Xp21. 3 region. Proc. Natl. Acad. Sci. USA 1995, 92, 4987-4991.
45. Dos Santos, N. R.; Torensma, R.; de Vries, T. J.; Schreurs, M. W.; de Bruijn, D. R.; Kater-Baats, E.; Ruiter, D. J.; Adema, G. J.; van Muijen, G. N.; van Kessel, A. G. Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines. Cancer Res. 2000, 60, 1654-1662.
46. Simpson, A. J.; Caballero, O. L.; Jungbluth, A.; Chen, Y. T.; Old, L. J. Cancer/testis antigens, gametogenesis and cancer. Nat. Rev. Cancer 2005, 5, 615-625.
47. Choi, J.; Chang, H. The expression of MAGE and SSX, and correlation of COX2, VEGF, and survivin in colorectal cancer. Anticancer Res. 2012, 32, 559-564.
48. Bottarelli, L.; Azzoni, C.; Necchi, F.; Lagrasta, C.; Tamburini, E.; D'Adda, T.; Pizzi, S.; Sarli, L.; Rindi, G.; Bordi, C. Sex chromosome alterations associate with tumor progression in sporadic colorectal carcinomas. Clin. Cancer Res. 2007, 13, 4365-4370.
49. Xiao, X. Y.; Zhou, X. Y.; Yan, G.; Sun, M. H.; Du, X. Chromosomal alteration in Chinese sporadic colorectal carcinomas detected by comparative genomic hybridization. Diagn. Mol. Pathol. 2007, 16, 96-103.
50. Lothe, R. A.; Peltomäki, P.; Meling, G. I.; Aaltonen, L. A.; Nyström-Lahti, M.; Pylkkänen, L.; Heimdal, K.; Andersen, T. I.; Møller, P.; Rognum, T. O.; et al. Genomic instability in colorectal cancer: Relationship to clinicopathological variables and family history. Cancer Res. 1993, 53, 5849-5852.
51. Muleris, M.; Dutrillaux, A. M.; Olschwang, S.; Salmon, R. J.; Dutrillaux, B. Predominance of normal karyotype in colorectal tumors from hereditary non-polyposis colorectal cancer patients. Genes Chromosomes Cancer 1995, 14, 223-226.
52. Goel, A.; Arnold, C. N.; Niedzwiecki, D.; Chang, D. K.; Ricciardiello, L.; Carethers, J. M.; Dowell, J. M.; Wasserman, L.; Compton, C.; Mayer, R. J.; et al. Characterization of sporadic colon cancer by patterns of genomic instability. Cancer Res. 2003, 63, 1608-1614.
53. Camps, J.; Armengol, G.; del Rey, J.; Lozano, J. J.; Vauhkonen, H.; Prat, E.; Egozcue, J.; Sumoy, L.; Knuutila, S.; Miró, R. Genome-wide differences between microsatellite stable and unstable colorectal tumors. Carcinogenesis 2006, 27, 419-428.
54. Trautmann, K.; Terdiman, J. P.; French, A. J.; Roydasgupta, R.; Sein, N.; Kakar, S.; Fridlyand, J.; Snijders, A. M.; Albertson, D. G.; Thibodeau, S. N.; et al. Chromosomal instability in microsatellite-unstable and stable colon cancer. Clin. Cancer Res. 2006, 12, 6379-6385.
55. Hawkins, N. J.; Tomlinson, I.; Meagher, A.; Ward, R. L. Microsatellite-stable diploid carcinoma: A biologically distinct and aggressive subset of sporadic colorectal cancer. Br. J. Cancer 2001, 84, 232-236.
56. Sinicrope, F. A.; Rego, R. L.; Halling, K. C.; Foster, N.; Sargent, D. J.; La Plant, B.; French, A. J.; Laurie, J. A.; Goldberg, R. M.; Thibodeau, S. N.; et al. Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients. Gastroenterology 2006, 131, 729-737.
57. Kazama, Y.; Watanabe, T.; Kanazawa, T.; Tanaka, J.; Tanaka, T.; Nagawa, H. Microsatellite instability in poorly differentiated adenocarcinomas of the colon and rectum: Relationship to clinicopathological features. J. Clin. Pathol. 2007, 60, 701-704.
58. Watanabe, T.; Kobunai, T.; Yamamoto, Y.; Matsuda, K.; Ishihara, S.; Nozawa, K.; Yamada, H.; Hayama, T.; Inoue, E.; Tamura, J.; et al. Chromosomal instability (CIN) phenotype, CIN high or CIN low, predicts survival for colorectal cancer. J. Clin. Oncol. 2012, 30, 2256-2264.
59. Al-Mulla, F. Microarray-based CGH and copy number analysis of FFPE samples. Methods Mol. Biol. 2011, 724, 131-145.